Tamil Nadu hospital shortage of surfactant drugs threatens premature infant care

Surfactant drugs are vital in neonatal intensive care units, enabling the lungs of premature infants to expand and function properly. Without timely administration of these medicines, newborns with underdeveloped lungs face severe respiratory complications that can prove life-threatening. Medical professionals across the state have reported persistent supply chain challenges affecting their ability to provide this essential treatment.

A survey of multiple government hospitals and healthcare practitioners in Tamil Nadu indicates that several centres are unable to maintain adequate stock levels of surfactant medications. The shortages have created logistical challenges for neonatal care teams managing cases of respiratory distress syndrome, a common complication in premature births.

The supply constraints come at a time when Tamil Nadu's government healthcare system continues to serve a significant proportion of the state's population, particularly in rural and semi-urban areas where private alternatives may be limited. Neonatal specialists have emphasized the time-sensitive nature of surfactant therapy, noting that delays in treatment can compromise clinical outcomes.

While the state government has not issued an official statement on the issue, healthcare administrators are expected to address the supply chain disruptions to ensure uninterrupted access to critical medications for vulnerable newborn patients across government facilities.